ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for acetaminophen; tramadol hydrochloride and what is the scope of freedom to operate?
Acetaminophen; tramadol hydrochloride
is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Amneal Pharms, Aurobindo Pharma, Chartwell Rx, Graviti Pharms, Macleods Pharms Ltd, Micro Labs Ltd India, Nostrum Labs Inc, Rising, Sun Pharm Inds Inc, Zydus Pharms Usa Inc, and Janssen Pharms, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.Seventeen suppliers are listed for this compound.
Summary for ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 12 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 17 |
| Clinical Trials: | 82 |
| DailyMed Link: | ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University Hospital "Sestre Milosrdnice" | N/A |
| Novartis Pharmaceuticals | Phase 3 |
| Bhupesh Parashar, MD | Phase 2 |
See all ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE clinical trials
Pharmacology for ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
US Patents and Regulatory Information for ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
Expired US Patents for ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Janssen Pharms | ULTRACET | acetaminophen; tramadol hydrochloride | TABLET;ORAL | 021123-001 | Aug 15, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| Janssen Pharms | ULTRACET | acetaminophen; tramadol hydrochloride | TABLET;ORAL | 021123-001 | Aug 15, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
